Welcome to our dedicated page for iPath® B S&P 500® VIX Md-Trm Futs™ ETN SEC filings (Ticker: VXZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for the iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) focuses on regulatory documents associated with the iPath ETN platform issued by Barclays Bank PLC. Barclays states that each iPath ETN series is governed by a prospectus supplement and a pricing supplement that are filed with the U.S. Securities and Exchange Commission (SEC). These documents set out the detailed terms of each ETN, including index linkage, calculation mechanics, fees, and risk factors.
In its public announcements, Barclays repeatedly directs investors to the applicable prospectus supplement and pricing supplement and to the section titled “Risk Factors” or “Selected Risk Considerations” for a fuller description of the risks associated with its ETNs. The filings explain that iPath ETNs are unsecured debt obligations of Barclays Bank PLC, are not obligations of or guaranteed by any third party, and may result in investors losing some or all of their principal. They also discuss market and volatility risk, liquidity considerations, and the uncertainty surrounding tax treatment.
On Stock Titan, this page aggregates the available SEC filings related to VXZ and the broader iPath ETN program. Real-time updates from the SEC’s EDGAR system allow users to see when new prospectus supplements, pricing supplements, or other registration statements are filed for Barclays’ ETNs. AI-powered summaries help explain the key points of lengthy documents, such as how payment on an ETN is determined, what events can trigger redemption, and which risk factors Barclays emphasizes for that series.
Although no VXZ-specific SEC filings are listed in the materials provided here, the general framework described by Barclays applies to iPath ETNs as a group. Investors can use this page to review historical and newly filed documents for VXZ when they are available, and to understand how Barclays presents credit risk, market risk, and structural features of its ETNs in formal SEC filings.
Barclays Bank has issued $1,766,000 in Callable Range Accrual Buffered Notes due June 28, 2030, linked to the Russell 2000 Index. The notes offer a contingent interest rate of 7.00% per annum (0.5833% monthly), but interest only accrues on days when the index closes at or above the Coupon Barrier Value of 1,815.76.
Key features include:
- Principal at risk: Investors could lose up to 85% of principal if index falls below buffer value
- Early redemption option: Barclays can call notes after first year on any interest payment date
- Buffer protection: 15% downside buffer from initial index value of 2,136.185
- Initial estimated value: $953.00 per $1,000 note
The notes are subject to Barclays' creditworthiness and U.K. Bail-in Power, which could result in the reduction, cancellation, or conversion of principal/interest. These complex securities are not bank deposits and carry no FDIC or UK FSCS protection.
Barclays Bank PLC has issued $1,684,000 in Fixed Coupon Buffered Notes due June 30, 2027, linked to the Russell 2000 Index. The notes offer a Fixed Coupon of $13.75 per $1,000 principal amount (5.50% per annum) paid quarterly.
Key features include:
- Initial issue price of $1,000 per note with minimum denomination of $1,000
- Buffer protection against first 15% of index decline
- Potential loss of up to 85% of principal if index falls below buffer value
- Estimated value of $968.80 per note, below issue price
Important risks: Notes are subject to Barclays' creditworthiness and U.K. Bail-in Power, which could result in complete loss of investment. Notes are not listed on any exchange, not FDIC insured, and involve market risk. Agent's commission is 2.50% with Barclays Capital receiving $25.00 per note in selling concessions.